Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 17;45(1):192.
doi: 10.1007/s10792-025-03554-x.

Intracameral medications in cataract surgery

Affiliations
Review

Intracameral medications in cataract surgery

Caglar Bektas et al. Int Ophthalmol. .

Abstract

Purpose: To review the indications, dosages, and safety profiles of intracameral drugs used during cataract surgery.

Methods: A narrative review was conducted, evaluating published clinical studies, review articles, and guidelines related to intracameral drug use in cataract surgery. The analysis focused on drugs commonly used for anesthesia, mydriasis, inflammation control, and intraoperative complication management. Special consideration was given to their utility in high-risk surgical scenarios, such as small pupils, intraoperative floppy iris syndrome, white or pediatric cataracts, and cases with zonular weakness.

Results: Intracameral drugs have proven beneficial in achieving effective anesthesia, maintaining pupil dilation, and controlling inflammation during cataract surgery. Their use is particularly advantageous in complex cases, including those with corneal opacity, posterior capsular rupture, or combined procedures like minimally invasive glaucoma surgery and premium IOL implantation. When prepared and administered properly, these agents contribute to safer and more efficient surgeries. However, improper preparation or dosing can lead to ocular toxicity, highlighting the importance of meticulous handling.

Conclusion: Intracameral drug administration is a valuable adjunct in cataract surgery, enabling surgeons to manage routine and complex cases more effectively. Understanding their appropriate use and potential risks is essential to maximize patient safety and surgical success.

Keywords: Administration; Cataract; Dose; Intracameral drugs; Side effects.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors have no competing interests to declare that are relevant to the content of this article. The authors have no relevant financial or non-financial interests to disclose.The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. Ethical approval: This article does not contain any studies with human participants or animals performed by any of the authors.

Similar articles

References

    1. Liu Y-C, Wilkins M, Kim T et al (2017) Cataracts. Lancet (London, England) 390:600–612. https://doi.org/10.1016/S0140-6736(17)30544-5 - DOI - PubMed
    1. Catterall WA (2002) Molecular mechanisms of gating and drug block of sodium channels. Novartis Found Symp 241:206–232 - DOI - PubMed
    1. Behndig A, Lindén C (1998) Aqueous humor lidocaine concentrations in topical and intracameral anesthesia. J Cataract Refract Surg 24:1598–1601. https://doi.org/10.1016/s0886-3350(98)80349-0 - DOI - PubMed
    1. Minakaran N, Ezra DG, Allan BDS (2020) Topical anaesthesia plus intracameral lidocaine versus topical anaesthesia alone for phacoemulsification cataract surgery in adults. Cochrane Database Syst. Rev. 2020
    1. Gills JP, Cherchio M, Raanan MG (1997) Unpreserved lidocaine to control discomfort during cataract surgery using topical anesthesia. J Cataract Refract Surg 23:545–550. https://doi.org/10.1016/s0886-3350(97)80211-8 - DOI - PubMed

MeSH terms

LinkOut - more resources